KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 104 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q2 2021. The put-call ratio across all filers is 1.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $3,278,000 | -30.1% | 329,798 | -17.2% | 0.01% | -31.6% |
| Q4 2021 | $4,689,000 | +9.8% | 398,352 | +6.2% | 0.02% | 0.0% |
| Q3 2021 | $4,272,000 | +5.0% | 375,100 | +70.7% | 0.02% | 0.0% |
| Q1 2021 | $4,068,000 | +241.6% | 219,800 | +57.0% | 0.02% | +171.4% |
| Q3 2019 | $1,191,000 | +151.3% | 140,000 | +300.0% | 0.01% | +250.0% |
| Q2 2019 | $474,000 | +444.8% | 35,000 | +600.0% | 0.00% | – |
| Q2 2018 | $87,000 | – | 5,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Spearhead Capital Advisors, LLC | 202,580 | $2,601,000 | 2.82% |
| Lion Point Capital, LP | 480,000 | $5,140,000 | 1.13% |
| HHLR ADVISORS, LTD. | 2,920,023 | $37,493,000 | 0.99% |
| TANG CAPITAL MANAGEMENT LLC | 600,000 | $7,704,000 | 0.94% |
| Rubric Capital Management LP | 1,446,107 | $18,568,000 | 0.94% |
| AlphaCentric Advisors LLC | 43,000 | $552,000 | 0.57% |
| RICE HALL JAMES & ASSOCIATES, LLC | 749,933 | $9,629,000 | 0.56% |
| Parkman Healthcare Partners LLC | 126,192 | $1,620,000 | 0.46% |
| Birchview Capital, LP | 30,000 | $385,000 | 0.27% |
| Baker Brothers Advisors | 2,799,577 | $35,947,000 | 0.24% |